Targeting the p300/CBP epigenetic pathway to overcome hormone therapy resistance in advanced prostate cancer

被引：0
|
作者：
Chen, Emily L.
Hawkey, Nathan
Thomas, Beatrice C.
Ware, Kathryn E.
Runyambo, Daniella
Caligiuri, Maureen
Wilker, Erik
Soderblom, Erik J.
Moseley, M. Arthur, III
Guichard, Sylvie M.
Armstrong, Andrew J.
Somarelli, Jason A.
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2021年 / 20卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-21-P204
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P204
引用
收藏
页数：2
相关论文
共 50 条
  • [1] p300 and CBP targeting in castration therapy resistant prostate cancer
    Furlan, Tobias
    Sampson, Natalie
    Santer, Frederic R.
    Culig, Zoran
    CANCER RESEARCH, 2019, 79 (13)
  • [2] Targeting CBP/p300 and its downstream transcriptional machinery in advanced prostate cancer
    Sardar, Sumaira
    Ravindranath, Lakshmi
    McNair, Christopher
    Chand, Saswati
    Yuan, Wei
    Bogdan, Denisa
    Welti, Jon
    Sharp, Adam
    Schiewer, Matthew
    Butler, Lisa
    de Bono, Johann
    Frese, Kris
    Brooks, Nigel
    Pegg, Neil
    Knudsen, Karen
    Shafi, Ayesha
    CANCER RESEARCH, 2023, 83 (07)
  • [3] Targeting the p300/CBP Axis in Lethal Prostate Cancer
    Welti, Jonathan
    Sharp, Adam
    Brooks, Nigel
    Yuan, Wei
    McNair, Christopher
    Chand, Saswati N.
    Pal, Abhijit
    Figueiredo, Ines
    Riisnaes, Ruth
    Gurel, Bora
    Rekowski, Jan
    Bogdan, Denisa
    West, William
    Young, Barbara
    Raja, Meera
    Prosser, Amy
    Lane, Jordan
    Thomson, Stuart
    Worthington, Jenny
    Onions, Stuart
    Shannon, Jonathan
    Paoletta, Silvia
    Brown, Richard
    Smyth, Don
    Harbottle, Gareth W.
    Gil, Veronica S.
    Miranda, Susana
    Crespo, Mateus
    Ferreira, Ana
    Pereira, Rita
    Tunariu, Nina
    Carreira, Suzanne
    Neeb, Antje J.
    Ning, Jian
    Swain, Amanda
    Taddei, David
    Schiewer, Matthew J.
    Knudsen, Karen E.
    Pegg, Neil
    de Bono, Johann S.
    CANCER DISCOVERY, 2021, 11 (05) : 1118 - 1137
  • [4] Targeting the CBP/p300 axis in lethal prostate cancer impacts DNA repair
    Sardar, Sumaira
    Ravindranath, Lakshmi
    McNair, Christopher
    Chand, Saswati N.
    Yuan, Wei
    Bogdan, Denisa
    Welti, Jonathan
    Sharp, Adam
    Schiewer, Matthew
    Butler, Lisa
    de Bono, Johann
    Frese, Kris
    Brooks, Nigel
    Pegg, Neil
    Knudsen, Karen
    Shafi, Ayesha A.
    CANCER RESEARCH, 2024, 84 (06)
  • [5] p300/CBP and cancer
    Narayanan Gopalakrishna Iyer
    Hilal Özdag
    Carlos Caldas
    Oncogene, 2004, 23 : 4225 - 4231
  • [6] p300/CBP and cancer
    Iyer, NG
    Özdag, H
    Caldas, C
    ONCOGENE, 2004, 23 (24) : 4225 - 4231
  • [7] Targeting cancer with selective cbp/p300 bromodomain inhibitors
    Jaleel, Mahaboobi
    Senaiar, Ramesh S.
    Abbineni, Chandrasekhar
    Renukappa, Girish A.
    Mukherjee, Subhendu
    Marappan, Sivapriya
    Samiulla, D. S.
    Aravind, A. B.
    Kumar, Naveen R.
    Reddy, Venkata Siva N.
    Babu, Asha
    Srinivas, Akhila P.
    Yadlapalli, Prasad
    Tgore, Suraj
    Raghavendra, N. R.
    Naik, Chandranath D.
    Giri, Sanjeev
    Antony, Thomas
    Nellore, Kavitha
    Chelur, Shekar
    Daginakatte, Girish
    Ravanti, laura
    Myllymaki, Mikko
    Wohlfahrt, Gerd
    Mattila, Elina
    Karlsson, Stefan
    Bjorkman, Mari
    Riikonen, Reetta
    Ikonen, Tarja
    Leimu, Laura
    Malmstrom, Chira
    Korjamo, Timo
    Moilanen, Anu
    Ramachandra, Murali
    Samajdar, Susanta
    CANCER RESEARCH, 2020, 80 (16)
  • [8] The coactivators CBP and p300 in androgen independent prostate cancer
    Debes, JD
    Culig, Z
    Tindall, DJ
    HORMONAL CARCINOGENESIS IV, 2005, : 494 - 500
  • [9] Targeting the estrogen receptor pathway in luminal breast cancer through inhibition of p300/CBP
    Waddell, Aaron
    Mahmud, Iqbal
    Tian, Guimei
    Liao, Daiqing
    CANCER RESEARCH, 2019, 79 (13)
  • [10] Targeting the catalytic HAT domain of CBP/p300 for the treatment of hormone-dependent breast and prostate cancers
    Hearn, K.
    Bevan, L.
    Chessari, G.
    Clark, M.
    Cons, B.
    Espana-agusti, J.
    Ferro, K.
    Hamlett, C.
    Howard, A.
    Lyons, J.
    Martins, V.
    Morgillo, C.
    Palmer, N.
    Rapti, M.
    Shah, A.
    Smyth, T.
    Unbekandt, M.
    Varshney, D.
    Ahn, M.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S33 - S33
12345